PDS BiotechnologyPDSB
那斯達克 · USD
1.01
-0.01
(-0.98%)
收盤 12/12 04:59 (UTC+8)
12/12 04:59 (UTC+8)
PDS BiotechnologyPDSB
1.01
-0.01
(-0.98%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 8,140 | 7,623 | 9,106 | 7,361 | 10,179 | 8,685 | 10,097 | 10,407 | 10,520 | 12,696 |
研發費用 | 4,576 | 4,213 | 5,831 | 4,530 | 6,804 | 4,528 | 6,704 | 7,466 | 6,449 | 8,005 |
推銷及管理費用 | 3,564 | 3,410 | 3,275 | 2,831 | 3,375 | 4,157 | 3,393 | 2,941 | 4,071 | 4,691 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -8,140 | -7,623 | -9,106 | -7,361 | -10,179 | -8,684 | -10,098 | -10,407 | -10,520 | -12,696 |
其他收入及費用 | 281 | 334 | 378 | 504 | 667 | 675 | 669 | 684 | 739 | 751 |
利息費用 | 1,150 | 2,144 | 931 | 1,096 | 1,215 | 1,188 | 1,175 | 1,175 | 1,069 | 995 |
稅前純益 | -9,009 | -9,434 | -9,659 | -7,952 | -10,727 | -9,197 | -10,603 | -10,898 | -10,849 | -12,941 |
所得稅 | - | - | -1,170 | - | - | -869 | - | - | - | -1,406 |
稅後純益 | -9,009 | -9,434 | -8,489 | -7,952 | -10,727 | -8,328 | -10,603 | -10,898 | -10,849 | -11,535 |
基本每股稅後盈餘(元) | -0.19 | -0.21 | -0.21 | -0.21 | -0.29 | -0.23 | -0.30 | - | -0.35 | -0.37 |
稀釋每股稅後盈餘(元) | -0.19 | -0.21 | -0.21 | -0.21 | -0.29 | -0.23 | -0.30 | -0.35 | -0.35 | -0.37 |
基本平均股數(千股) | 46869.00 | 45902.00 | 40521.00 | 37496.00 | 36806.00 | 36693.00 | 34815.00 | - | 30910.00 | 30802.00 |
稀釋平均股數(千股) | 46869.00 | 45902.00 | 40521.00 | 37496.00 | 36806.00 | 36693.00 | 34815.00 | - | 30910.00 | 30802.00 |
還原基本每股稅後盈餘(元) | -0.19 | -0.21 | -0.21 | -0.21 | -0.29 | -0.23 | -0.30 | - | -0.35 | -0.37 |
還原稀釋每股稅後盈餘(元) | -0.19 | -0.21 | -0.21 | -0.21 | -0.29 | -0.23 | -0.30 | -0.35 | -0.35 | -0.37 |
還原基本平均股數(千股) | 46,869 | 45,902 | 40,521 | 37,496 | 36,806 | 36,693 | 34,815 | - | 30,910 | 30,802 |
還原稀釋平均股數(千股) | 46,869 | 45,902 | 40,521 | 37,496 | 36,806 | 36,693 | 34,815 | - | 30,910 | 30,802 |
EBITDA(千元) | -8,151 | -6,161 | -8,440 | -6,543 | -9,192 | -7,710 | -9,143 | -9,449 | -9,607 | -11,820 |